Literature DB >> 11786016

Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.

Aphrodite Kapurniotu1, Anke Schmauder, Konstantinos Tenidis.   

Abstract

Pancreatic amyloid is formed by the aggregation of the 37-residue islet amyloid polypeptide (IAPP) in type II diabetes patients and is cytotoxic. Pancreatic amyloid deposits are found in more than 95 % of type II diabetes patients and their formation is strongly associated with disease progression. IAPP amyloid forms via a conformational transition of soluble IAPP into aggregated beta-sheets. We recently identified IAPP(22-27) (NFGAIL) as a minimum length sequence sufficient to self-associate into beta-sheet-containing amyloid fibrils. Here, we have used the NFGAIL model of the IAPP amyloid core as a structural template to design non-amyloidogenic derivatives of amyloidogenic sequences of IAPP that are able to interact with the native sequences and inhibit amyloid formation. The design of the derivatives was based on a simple, structure-based minimalistic and selective N-methylation approach. Accordingly, a minimum number of two amide bonds on the same side of the beta-strand of the amyloid core was N-methylated. This was expected to eliminate the two intermolecular backbone NH to CO hydrogen bonds which are critical for the extension of the beta-sheet dimers into multimers and amyloid. Other beta-strand "contact sides" remained intact allowing for the derivatives to interact with the native sequences. Double N-methylated derivatives of amyloidogenic and cytotoxic partial IAPP sequences generated included F(N-Me)GA(N-Me)IL, NF(N-Me)GA(N-Me)IL, SNNF(N-Me)GA(N-Me)IL, and SNNF(N-Me)GA(N-Me)ILSS and were found to be devoid of beta-sheet structure, amyloidogenicity and cytotoxicity according to Fourier transform-infrared spectroscopy (FT-IR), Congo red (CR) staining, electron microscopy (EM), and cell viability tests. The derivatives were able to interact with the native sequences and inhibit amyloid formation as shown by circular dichroism spectroscopy (CD), FT-IR and EM. Moreover, SNNF(N-Me)GA(N-Me)ILSS inhibited cytotoxicity of SNNFGAILSS and is thus the first reported inhibitor of IAPP amyloid formation and cytotoxicity. Our results demonstrate the validity of the design approach for IAPP and suggest that it may find application in understanding the structural features of amyloid formation and in the development of inhibitors of amyloid formation and cytotoxicity of other amyloidogenic polypeptides as well. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786016     DOI: 10.1006/jmbi.2001.5244

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  48 in total

1.  Short peptide amyloid organization: stabilities and conformations of the islet amyloid peptide NFGAIL.

Authors:  David Zanuy; Buyong Ma; Ruth Nussinov
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

2.  The amyloid formation mechanism in human IAPP: dimers have β-strand monomer-monomer interfaces.

Authors:  Nicholas F Dupuis; Chun Wu; Joan-Emma Shea; Michael T Bowers
Journal:  J Am Chem Soc       Date:  2011-04-25       Impact factor: 15.419

3.  Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

Authors:  Takeshi Sato; Pascal Kienlen-Campard; Mahiuddin Ahmed; Wei Liu; Huilin Li; James I Elliott; Saburo Aimoto; Stefan N Constantinescu; Jean-Noel Octave; Steven O Smith
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

4.  Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.

Authors:  Jacqueline F Aitken; Kerry M Loomes; Barbara Konarkowska; Garth J S Cooper
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

5.  Effect of sequence variation on the mechanical response of amyloid fibrils probed by steered molecular dynamics simulation.

Authors:  Hlengisizwe Ndlovu; Alison E Ashcroft; Sheena E Radford; Sarah A Harris
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

6.  Graphene oxide inhibits hIAPP amyloid fibrillation and toxicity in insulin-producing NIT-1 cells.

Authors:  Praveen Nedumpully-Govindan; Esteban N Gurzov; Pengyu Chen; Emily H Pilkington; William J Stanley; Sara A Litwak; Thomas P Davis; Pu Chun Ke; Feng Ding
Journal:  Phys Chem Chem Phys       Date:  2015-12-02       Impact factor: 3.676

7.  Molecular basis for insulin fibril assembly.

Authors:  Magdalena I Ivanova; Stuart A Sievers; Michael R Sawaya; Joseph S Wall; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

8.  Solution state structures of human pancreatic amylin and pramlintide.

Authors:  John R Cort; Zhihong Liu; Gregory M Lee; K N L Huggins; Susan Janes; Kathryn Prickett; Niels H Andersen
Journal:  Protein Eng Des Sel       Date:  2009-07-12       Impact factor: 1.650

Review 9.  The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.

Authors:  John Grizzanti; Hyoung-Gon Lee; Antoni Camins; Merce Pallas; Gemma Casadesus
Journal:  Nutr Res       Date:  2016-11-08       Impact factor: 3.315

10.  Rational design of potent domain antibody inhibitors of amyloid fibril assembly.

Authors:  Ali Reza A Ladiwala; Moumita Bhattacharya; Joseph M Perchiacca; Ping Cao; Daniel P Raleigh; Andisheh Abedini; Ann Marie Schmidt; Jobin Varkey; Ralf Langen; Peter M Tessier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.